AGRANULOCYTOSIS DURING COMBINED PROCAINAMIDE AND PHENYTOIN THERAPY

被引:18
作者
CROOK, JE
WOOSLEY, RL
LEFTWICH, RB
NATELSON, EA
机构
[1] Department of Pharmacology, Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN
关键词
D O I
10.1097/00007611-197912000-00032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1599 / 1601
页数:3
相关论文
共 6 条
[1]  
LAWSON DH, 1977, BRIT J CLIN PHARMACO, V4, P507, DOI 10.1111/j.1365-2125.1977.tb00777.x
[2]   DRUG-INDUCED AGRANULOCYTOSIS [J].
PISCIOTTA, V .
DRUGS, 1978, 15 (02) :132-143
[3]   AGRANULOCYTOSIS ASSOCIATED WITH PROCAINAMIDE THERAPY - REPORT OF A CASE [J].
PRINCE, RA ;
BROWN, BT ;
JACKNOWITZ, AI .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (12) :1362-1365
[4]  
REIDENBERG MM, 1975, CLIN PHARMACOL THER, V17, P722
[5]   DILANTIN, AGRANULOCYTOSIS, AND PHAGOCYTIC MARROW HISTOCYTES [J].
TSAN, MF ;
MEHLMAN, DJ ;
GREEN, RS ;
BELL, WR .
ANNALS OF INTERNAL MEDICINE, 1976, 84 (06) :710-711
[6]   EFFECT OF ACETYLATOR PHENOTYPE ON RATE AT WHICH PROCAINAMIDE INDUCES ANTI-NUCLEAR ANTIBODIES AND LUPUS SYNDROME [J].
WOOSLEY, RL ;
DRAYER, DE ;
REIDENBERG, MM ;
NIES, AS ;
CARR, K ;
OATES, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (21) :1157-1159